Management of Obesity
Webcast CME Disclosure
Please read this notice and click the acknowledgement
at the bottom of the page to continue.
Estimated Time to Complete Educational Activity
In this web-based program, physicians will learn how recent advances in basic and clinical research have helped to advance the understanding of treatment advances in obesity management.
December 12, 2012
December 12, 2014
Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CME credit for this activity. During the period December 12, 2012 through December 12, 2014, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view all six segments totaling 3.5 hours to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form; 4) score 100% on the post-test; and 5) print out your CME certificate.
Participation in this WebCAST is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Supported by an educational grant from Eisai, Inc.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Complete Conference Management and CMEducation Resources, LLC. Complete Conference Management is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
Complete Conference Management designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policy on Faculty & Provider Disclosure
It is the policy of Complete Conference Management to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by Complete Conference Management are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.
Program Faculty and Disclosure
HAROLD E. BAYS, MD, FACP, FACE, FNLA – Program Chairman
Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC)
Research Grants: Eisai, Novo Nordisk, VIVUS, Orexigen
Consultant/Advisory Board: Eisai, VIVUS
CAROLINE APOVIAN, MD, FACP, FACN
Professor of Medicine and Pediatrics
Boston University School of Medicine
Director, Nutrition and Weight Management
Boston Medical Center
Research Grants: Orexigen Therapeutics, Amylin, GI Dynamics, MetaProteomics, Atkins Foundation
Consultant/Advisory Board: Orexigen Therapeutics, Amylin, Johnson & Johnson, Merck, Pfizer, Zafgen, GI Dynamics, Abbott, Novo Nordisk, sanofi-aventis
ERIC RAVUSSIN, PhD
Chief, Division of Health and Performance Enhancement
Douglas L. Gordon Chair in Diabetes and Metabolism
Louisiana State University/Pennington Biomedical Research Center
Baton Rouge, LA
Employment: Eli Lilly
Research Grant: Arena Pharmaceuticals
Patrick M. O'Neil, PhD
Director, Weight Management Center
Professor, Department of Psychiatry and Behavioral Sciences
Medical University of South Carolina
Research Grants: Weight Watchers International, Orexigen Therapeutics, Arena Pharmaceuticals
Speaker Honoraria: Vivus, Pharmatecture LLC
Consultant/Advisory Board: Orexigen Therapeutics, MEDACorp/Leerink Swann LLC
Travel Support: Arena Pharmaceuticals
Program Managers and Web Editor Disclosure
Program Manager Gideon Bosker, MD has nothing to disclose.
Upon completion of this activity, participants will be able to:
- Recognize and apply the clinical criteria for being overweight or obese, and understand the implications of this classification on other health markers and disease states, including diabetes, heart disease, cancer, and related disease states
- Apply both BMI criteria and DEXA measurements to become more proficient at screening for overweight status and obesity
- Manage obesity as a primary "risk factor" in the setting of common cardiovascular and cardiometabolic conditions including CAD and T2D; and become proficient at weight loss interventions within the setting of internal medicine- and primary care-based specialty care
- Employ multimodal strategies, including pharmacologic management, to effect weight reduction in high risk, overweight individuals with co--morbid conditions
- Deploy pharmacologic therapies that work through neurological and neurophysiological targets for appetite dysregulation
Hardware and Software Requirements:
To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.
When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:
- We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
- For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
- We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
- If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
Copyright © 2012 by Pharmatecture, LLC and CMEducation Resources, LLC All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.
Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.
||I have read
this CME information statement and wish to participate in this CME
Copyright © CMEducation Resources, LLC and Pharmatecture, LLC